These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19758173)

  • 1. Galectin-10, eosinophils, and celiac disease.
    De Re V; Simula MP; Cannizzaro R; Pavan A; De Zorzi MA; Toffoli G; Canzonieri V
    Ann N Y Acad Sci; 2009 Sep; 1173():357-64. PubMed ID: 19758173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
    Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
    Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
    Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.
    Romanos J; van Diemen CC; Nolte IM; Trynka G; Zhernakova A; Fu J; Bardella MT; Barisani D; McManus R; van Heel DA; Wijmenga C
    Gastroenterology; 2009 Sep; 137(3):834-40, 840.e1-3. PubMed ID: 19454285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQ and risk gradient for celiac disease.
    Megiorni F; Mora B; Bonamico M; Barbato M; Nenna R; Maiella G; Lulli P; Mazzilli MC
    Hum Immunol; 2009 Jan; 70(1):55-9. PubMed ID: 19027045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiac disease: caught between a rock and a hard place.
    Koning F
    Gastroenterology; 2005 Oct; 129(4):1294-301. PubMed ID: 16230082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis.
    Koskela RM; Karttunen TJ; Niemelä SE; Lehtola JK; Ilonen J; Karttunen RA
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):276-82. PubMed ID: 18334870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.
    Pietzak MM; Schofield TC; McGinniss MJ; Nakamura RM
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):966-71. PubMed ID: 19500688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic background of celiac disease and its clinical implications.
    Wolters VM; Wijmenga C
    Am J Gastroenterol; 2008 Jan; 103(1):190-5. PubMed ID: 18184122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury.
    Simone R; Brizzolara R; Chiappori A; Milintenda-Floriani F; Natale C; Greco L; Schiavo M; Bagnasco M; Pesce G; Saverino D
    Int Immunol; 2009 Sep; 21(9):1037-45. PubMed ID: 19625381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based identification of differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients.
    Liu X; Feng Q; Chen Y; Zuo J; Gupta N; Chang Y; Fang F
    J Proteome Res; 2009 Mar; 8(3):1255-62. PubMed ID: 19125585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies?
    Leonardi S; Spina M; Spicuzza L; Rotolo N; La Rosa M
    Vaccine; 2009 Oct; 27(43):6030-3. PubMed ID: 19682619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.
    Simula MP; Cannizzaro R; Canzonieri V; Pavan A; Maiero S; Toffoli G; De Re V
    Mol Med; 2010; 16(5-6):199-209. PubMed ID: 20454521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry analysis of gliadins in celiac disease.
    Ferranti P; Mamone G; Picariello G; Addeo F
    J Mass Spectrom; 2007 Dec; 42(12):1531-48. PubMed ID: 18085572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabonomic signature of celiac disease.
    Bertini I; Calabrò A; De Carli V; Luchinat C; Nepi S; Porfirio B; Renzi D; Saccenti E; Tenori L
    J Proteome Res; 2009 Jan; 8(1):170-7. PubMed ID: 19072164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staining efficiency of specific proteins depends on the staining method: wheat gluten proteins.
    van den Broeck HC; America AH; Smulders MJ; Gilissen LJ; van der Meer IM
    Proteomics; 2008 May; 8(9):1880-4. PubMed ID: 18398878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA types in Turkish children with celiac disease.
    Kuloğlu Z; Doğanci T; Kansu A; Demirçeken F; Duman M; Tutkak H; Ensari A; Girgin N
    Turk J Pediatr; 2008; 50(6):515-20. PubMed ID: 19227412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microflora associated characteristics in first-degree relatives of children with celiac disease.
    Tjellström B; Stenhammar L; Högberg L; Fälth-Magnusson K; Magnusson KE; Midtvedt T; Sundqvist T; Houlston R; Popat S; Norin E
    Scand J Gastroenterol; 2007 Oct; 42(10):1204-8. PubMed ID: 17852880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.